The recurrence of kidney stone, after removal, can be reduced by the use of potassium citrate. However, the palatability of the product is poorly accepted and this can give rise to failure of treatment when patients do not comply.
Urocit K is a special formula where the potassium citrate is embedded in a wax matrix tablet, which is released slowly after it enters the digestive system. This negates the negative taste.
Moreover, the slow release of potassium citrate ensures that the absorption is constant and the inhibitory effect of the ingredients is maintained in a sustainable manner.